Everest Organics Q1 FY27 results: auditor flags TSPCB compliance issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q1 FY27 results: Sales turnover of Rs 4,843 lakhs (Domestic Rs 3,764.83L, Exports Rs 1,078.23L). PAT was Rs 111.34 lakhs vs Rs 140.52 lakhs in Q1 FY26, a YoY decline. EPS Rs 1.15 vs Rs 1.45. Auditors issued a qualified limited review report flagging TSPCB pollution control non-compliance with enhanced production beyond consented capacity, warning of potential going concern impact and closure order risk.
Auditor qualification and going concern warning over pollution compliance may weigh on the stock. PAT declined about 21% YoY, adding concern.